Author: Okeke, Francis; Mone, Anjali; Swaminath, Arun
                    Title: The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection  Cord-id: fptdd7qe  Document date: 2020_8_15
                    ID: fptdd7qe
                    
                    Snippet: The Inflammatory Bowel Disease (IBD) population, which may require treatment with immunosuppressive medications, may be uniquely vulnerable to COVID-19 infection. In fact, there is some evidence these medications may inhibit the cytokine storm that is theorized to cause a rapid decline seen in COVID-19. In addition, the digestive symptoms of COVID-19 can be difficult to distinguish from the activation of IBD. We present an interesting case of a Crohn’s patient inadvertently administering anti-
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: The Inflammatory Bowel Disease (IBD) population, which may require treatment with immunosuppressive medications, may be uniquely vulnerable to COVID-19 infection. In fact, there is some evidence these medications may inhibit the cytokine storm that is theorized to cause a rapid decline seen in COVID-19. In addition, the digestive symptoms of COVID-19 can be difficult to distinguish from the activation of IBD. We present an interesting case of a Crohn’s patient inadvertently administering anti-cytokine therapy during the pre-symptomatic period of COVID-19 infection. Immune suppression during early infection with SARS-COV2 risks a poor immune response to the virus and could theoretically result in a more severe course of infection.
 
  Search related documents: 
                                Co phrase  search for related documents- abdominal ct scan and acute phase: 1
  - abdominal ct scan and acute respiratory: 1, 2, 3, 4, 5, 6, 7
  - abdominal ct scan and acute respiratory distress syndrome: 1
  - abdominal ct scan and liver function: 1
  - abdominal ct scan and lupus erythematosus: 1
  - aberrant immune response and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
  - aberrant immune response and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
  - aberrant immune response and lupus erythematosus: 1, 2
  - abnormal ct scan and acute phase: 1
  - abnormal ct scan and acute respiratory: 1, 2, 3, 4
  - acute phase and additional intervention: 1
  - acute phase and liver function: 1, 2, 3, 4, 5, 6, 7
  - acute phase and lupus erythematosus: 1, 2
  - acute respiratory and additional intervention: 1, 2, 3, 4, 5, 6
  - acute respiratory and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
  - acute respiratory and liver function test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
  - acute respiratory and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
  - acute respiratory distress syndrome and additional intervention: 1, 2
  - acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date